Observational studyPloS one2026
Predictive value of neutrophil-to-lymphocyte ratio on hospital outcomes of patients with community-acquired pneumonia.
Observational study in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCommunity-acquired pneumonia (CAP) remains a leading cause of hospitalization and mortality worldwide, particularly in low- and middle-income countries. Risk stratification is essential for guiding treatment decisions, yet commonly used biomarkers such as C-reactive protein and procalcitonin are costly and not always readily available. The neutrophil-to-lymphocyte ratio (NLR), a simple index derived from routine blood counts, has been proposed as a cost-effective prognostic marker. This study aimed to evaluate the predictive value of NLR on hospital outcomes in patients with CAP.
methodsA prospective observational study was conducted in the Department of Medicine at Dhaka Medical College Hospital, Bangladesh, between July 2023 and June 2024. One hundred adult patients with CAP were enrolled using purposive sampling. Demographic, clinical, and laboratory data were recorded at admission, including complete blood counts and CURB-65 scores. NLR was calculated, with ≥7.12 defined as elevated. Patients were followed for outcomes including mortality, oxygen requirement, ICU admission, and length of hospital stay. Statistical analyses included chi-square tests, logistic regression, and ROC curve analysis.
resultsThe mean age of participants was 53.7 ± 10.9 years, and 62% were male. An elevated NLR (≥7.12) was present in 67% of patients and was significantly associated with mortality (p = 0.027), oxygen requirement (p < 0.001), ICU admission (p < 0.005), and prolonged hospital stay (p < 0.001). Regression analysis confirmed NLR ≥ 7.12 is associated with prolonged stay (OR: 15.235; 95% CI: 4.613-50.316; p < 0.001), oxygen requirement (OR: 1.846; 95% CI: 1.415-2.408; p < 0.001), ICU transfer (OR: 5.172; 95% CI: 1.289-20.747; p < 0.001), and mortality (OR: 7.704; 95% CI: 1.962-61.690). ROC analysis showed moderate discriminatory ability for prolonged stay (AUC: 0.762) and modest predictive performance for oxygen need, ICU admission, and mortality.
conclusionElevated NLR is strongly associated with adverse outcomes in CAP, including mortality, ICU admission, oxygen requirement, and prolonged hospitalization. Given its simplicity and accessibility, NLR may serve as a valuable tool for early risk stratification in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.